Home Biosimilar Antibodies NF-κB NF-κB inhibitor Denosumab (anti-RANK ligand) For research use only.
Not for use in humans.

Denosumab (anti-RANK ligand)

Synonyms: AMG-162

Denosumab (anti-RANK ligand) (AMG-162) is a fully human monoclonal antibody that selectively inhibits primate RANKL. Denosumab inhibits the ability of human RANKL (143–317) to stimulate the formation of osteoclasts derived from murine RAW 264.7 cells with an IC50 value of 1.64 nM.

Denosumab (anti-RANK ligand)

Click to purchase the isotype control of Denosumab (anti-RANK ligand)

Selleck's Denosumab (anti-RANK ligand) has been cited by 4 publications

Purity & Quality Control

Choose Selective NF-κB Inhibitors

Name Citation NF-κB Others
QNZ (EVP4593) 152 TNF-α
JSH-23 160
B022 0
UCB-9260 0 TNF
Morusin 0 STAT3
IQ 3 1 TNF-α,IL-6,JNK3
CBL0137 9 FACT,p53
NIK SMI1 0
Ginsenoside Rb3 1 iNOS,COX-2
Ginsenoside Rd 4 iNOS,COX-2,Ca2+ influx
CBL0137 HCl 9 FACT,p53
SC75741 52
TPCA-1 70 STAT3,IKK2
Bardoxolone Methyl 34 IKK,Ferroptosis,Nrf2
Curcumin 49 Nrf2,Ferroptosis,HDAC
Sodium 4-Aminosalicylate 2
Caffeic Acid Phenethyl Ester 55
Sodium salicylate 1
HOIPIN-8 0
EN450 0
Chitosan oligosaccharide 0
NF-κB-IN-1 2
SM-7368 0
sappanone A 0
Okanin 0 TLR4
Rubiadin 1-methyl ether 0
Cornuside 0
BTYNB 0
TCEP Hydrochloride 2
IMM-H007 0 ABCA1,JNK/AP1,AMPK
Urolithin B 0 ERK,JNK,IκBα
L-Quebrachitol 0 Wnt/β-catenin,MAPK,Runx2
Licochalcone D 0 EGFR,JAK2,PARP
Tectochrysin 0
Caulophylline (N-Methylcytisine) 0 IκB,MPO,IKK
Myrislignan 1 COX-2,iNOS,TNF-α
NDMC101 0
Gardenoside 0 IL-6,IL-1β,TNF-α
Cucurbitacin IIb 0 IκBα,ERK1/2,JNK
Jaceosidin 0 Mcl-1,Bax,COX-2
Isoliquiritin apioside 0 MAPK,MMP
Withaferin A (WFA) 12 vimentin
Rocaglamide 3 eIF4A,HSF1
Xanthatin 0 STATs
Alobresib (GS-5829) 0 MYC,ERK1/2,Akt
Adjudin 1 ERK,Cl⁻ channel
IAXO-102 0 MAPK,TLR4
C25-140 0 TRAF6-Ubc13
SN50 4
INH14 0 IKKβ,IKKα
TAK-243 (MLN7243) 70 UAE
Sulforaphane 21 Nrf2,HO-1,ROS
Madecassic acid 1 IL-1β,TNF-α,COX-2
Homoplantaginin 1 IL-6,IKKβ,TNF-α
(+)-Praeruptorin A 0
2',5'-Dihydroxyacetophenone 1 IL-6,TNF-α,ERK1/2
Dauricine 1
8-O-acetyl shanzhiside methyl ester 0
Forsythoside B 0 IκB,IL-6,TNF-alpha
Engeletin 2
Berbamine 8 CaMKII,Bcr-Abl
Eleutheroside E 0
Mulberroside A 0 Caspase-1,NALP3,IL-6
Maslinic acid 1
Chelidonic acid 0 glutamate decarboxylase,IL-6,Caspase-1
Hyperoside 5
Vanillic acid 0
4'-Hydroxychalcone 0
(+)-α-Lipoic acid 1 LTR
4-Hydroxychalcone 2
Neferine 5
Benfotiamine 1
Ginsenoside Rb1 4 IFN-β,TNF-α,TLR4
Ginsenoside Rg1 4 Aβ
Guaiacol 0 COX-2
(E)-Cardamonin 0 TRPA1
Hederagenin 0 COX-2,iNOS
Ginsenoside Re 1 JNK,Aβ
Scutellarin 1 Akt,STAT3
Mangiferin 1 Nrf2
Schisantherin A 0
Curcumenol 3 CYP3A4
Muscone 3 TNF-α,IL-1β,NLRP3 inflammasome
Tyrosol 0
Stachydrine 3
Sodium Aescinate 2
Dehydroevodiamine 0 PGE2,iNOS,COX-2
Astragaloside IV 3 mTOR,Akt,ERK
4'-Methoxyresveratrol 0 NLRP3
Berbamine dihydrochloride 2 CaMKII,Bcr-Abl
Sarsasapogenin 1 IκBα,TAK1,IRAK1
(±)-Shikonin 38 Proteasome,chemokine receptor,TNF-α
Diethylmaleate 0 Nrf2
Omaveloxolone (RTA-408) 9 Nrf2
DTP3 2 GADD45β/MKK7
APX-3330 5 APE1(Ref-1)
Triptolide 46 MDM2,HSF1
Methylthiouracil 0 ERK1/2,IL-6,TNF-α
Erdosteine 0
Evodiamine 9
Vanillylacetone 1
(-)-Parthenolide 26 p53,MDM2,HDAC1
Magnolol 7
Indole-3-carbinol 3
DHA (Dihydroartemisinin) 34
Andrographolide 10
Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description Denosumab (anti-RANK ligand) (AMG-162) is a fully human monoclonal antibody that selectively inhibits primate RANKL. Denosumab inhibits the ability of human RANKL (143–317) to stimulate the formation of osteoclasts derived from murine RAW 264.7 cells with an IC50 value of 1.64 nM.
  • https://pubmed.ncbi.nlm.nih.gov/19016581/
  • https://pubmed.ncbi.nlm.nih.gov/29435849/

Product Details

CAS No. 615258-40-7
Molecular Weight 145.16 kDa
Isotype human IgG1
Source HEK293
Sterility 0.2 μM filtered
Formulation PBS Buffer, pH 7.4
Storage
(From the date of receipt)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.